Related Experiment Video

Updated: Nov 3, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.6K

Directly observed therapy to promote medication adherence in paediatric heart transplant recipients

Michael O Killian1,2, Stephanie A Clifford3,4, Dipankar Gupta3,5

  • 1College of Social Work, Florida State University, Tallahassee, FL, USA.

Cardiology in the Young
|June 7, 2021
PubMed

Insights

Medication non-adherence impacts pediatric organ transplant outcomes. This pilot study explores mobile video directly observed therapy to improve adherence in pediatric organ transplant recipients.

Area of Science:

  • Pediatric Organ Transplantation
  • Mobile Health (mHealth)
  • Medication Adherence

Background:

  • Medication non-adherence is a significant challenge in pediatric organ transplantation, leading to adverse patient outcomes.
  • The COVID-19 pandemic accelerated the adoption of mobile health (mHealth) technologies in patient care.
  • Emerging trends highlight the potential of mHealth for improving medication adherence.

Purpose of the Study:

  • To pilot a mobile video directly observed therapy (VDOT) intervention.
  • To assess the feasibility and potential impact of VDOT on medication adherence in pediatric organ transplant recipients.
  • To build on emerging trends in mHealth for medication adherence.

Main Methods:

  • Pilot intervention study design.
  • Utilized mobile video directly observed therapy (VDOT).
  • Focused on pediatric organ transplant patients.

Main Results:

  • The study describes a pilot intervention using mobile VDOT.
  • Building on emerging trends in research and clinical practice.
  • Focuses on medication adherence in pediatric organ transplantation.

Conclusions:

  • Mobile VDOT represents a promising approach for improving medication adherence in pediatric organ transplantation.
  • Further research is warranted to validate the efficacy of VDOT in this population.
  • Leveraging mHealth technologies can enhance post-transplant care and outcomes.

Keywords:
Paediatric organ transplantationadolescentmHealthmedication adherence

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.7K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.1K

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
122
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
132
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
47
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
286
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
69